Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/48926
Título: One-year continuous inhaled nitric oxide for primary pulmonary hypertension
Autores/as: Pérez-Peñate, Gregorio 
Juliá-Serdá, Gabriel
Pulido-Duque, Juan María
Górriz-Gómez, Elias
Cabrera-Navarro, Pedro 
Clasificación UNESCO: 32 Ciencias médicas
320508 Enfermedades pulmonares
Palabras clave: Pulmonary hypertension
Nitric oxide
Vasodilator agents
Fecha de publicación: 2001
Publicación seriada: Chest (American College of Chest Physicians) 
Resumen: We describe a case of long-term administration of nitric oxide (NO) in a 32-year-old man who was admitted with exertional dyspnea and anasarca. A diagnosis of primary pulmonary hypertension was made. An acute vasodilator trial with inhaled NO showed a 5% reduction of the mean pulmonary artery pressure. Long-term NO inhalation therapy was initiated. Twenty days later, the dyspnea improved, the anasarca resolved, and the PaO(2) level increased. After 12 months of NO therapy, the patient remained stable and no signs of toxicity or tachyphylaxis were observed. To our knowledge, this is the first report of 1 year of continuously inhaled NO in an adult patient with primary pulmonary hypertension. These findings suggest that prolonged NO therapy might be an effective alternative, at a lower cost, to the continuous IV infusion of epoprostenol.
URI: http://hdl.handle.net/10553/48926
ISSN: 0012-3692
DOI: 10.1378/chest.119.3.970
Fuente: Chest[ISSN 0012-3692],v. 119(3), p. 970-973 (Marzo 2001)
Colección:Artículos
Vista completa

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.